Preclinical characterization of ALG-031048, a novel STING agonist with potent anti-tumor activity in mice

被引：7

作者：

Jekle, Andreas ^{[1
]}

Thatikonda, Santosh ^{[1
]}

Stevens, Sarah ^{[1
]}

Williams, Caroline ^{[1
]}

Kinkade, April ^{[1
]}

Ren, Suping ^{[1
]}

Jaisinghani, Ruchika ^{[1
]}

Zhang, Qingling ^{[1
]}

Misner, Dinah ^{[1
]}

Stoycheva, Antitsa ^{[1
]}

Deval, Jerome ^{[1
]}

Mukherjee, Sucheta ^{[1
]}

Gonzalvez, Francois ^{[2
]}

Chanda, Sushmita ^{[1
]}

Smith, David B. ^{[1
]}

Symons, Julian A. ^{[1
]}

Blatt, Lawrence M. ^{[1
]}

Beigelman, Leonid ^{[1
]}

机构：

[1] Aligos Therapeut, San Francisco, CA USA

[2] Aligos Belgium, Leuven, Belgium

来源：

CANCER RESEARCH | 2020年 / 80卷 / 16期

关键词：

D O I：

10.1158/1538-7445.AM2020-4520

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

4520

引用

页数：2

共 50 条

[11] A novel docetaxel derivative exhibiting potent anti-tumor activity and high safety in preclinical animal models
Wang, Yao
Wang, Penghui
Zhou, Linzhu
Su, Yue
Zhou, Yongfeng
Zhu, Xinyuan
Huang, Wei
Yan, Deyue
BIOMATERIALS SCIENCE, 2022, 10 (17) : 4876 - 4888
[12] Vorolanib, a novel tyrosine receptor kinase receptor inhibitor with potent preclinical anti-angiogenic and anti-tumor activity
Liang, Chris
Yuan, Xiaobin
Shen, Zhilin
Wang, Yang
Ding, Lieming
MOLECULAR THERAPY-ONCOLYTICS, 2022, 24 : 577 - 584
[13] Preclinical characterization of a novel STING agonist, MK-1454
Cemerski, Saso
Altman, Michael
Bandi, Madhavi
Chang, Wonsuk
Chen, Yiping
Cui, Long
Cumming, Jared
Dorosh, Lauren
Flateland, Lauren
Ma, Yanhong
Javaid, Sarah
Ho, Thu
Kopinja, Johnny
Laskey, Jason
Minnihan, Ellen
Price, Laura
Mogg, Robin
O'Donnell, Gregory
Pan, Bo-Sheng
Perera, Samanthi
Piesvaux, Jennifer
Presland, Jeremy
Rakhilina, Larissa
Schroeder, Gottfried
Slavonic, Michael
Smock, Steven
Trotter, Benjamin Wesley
Wyss, Daniel
Zhao, Qing
Zhao, Shuxia
Sadekova, Svetlana
Yu, Ying
Khilnani, Anuradha
Tse, Archie
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
[14] Preclinical pharmacology of ABT-518, a novel and potent inhibitor of gelatinase A and B with anti-tumor activity.
Albert, DH
Morgan, DW
Magoc, T
Tapang, P
Kherzai, A
Marcotte, P
Elmore, I
Glaser, K
Pease, L
Li, J
Leal, J
Michaelides, M
Curtin, M
Holms, J
Wada, C
Dai, Y
Davidson, SK
CLINICAL CANCER RESEARCH, 2000, 6 : 4525S - 4525S
[15] TETROCARCINS, NOVEL ANTI-TUMOR ANTIBIOTICS .2. ISOLATION, CHARACTERIZATION AND ANTI-TUMOR ACTIVITY
TAMAOKI, T
KASAI, M
SHIRAHATA, K
OHKUBO, S
MORIMOTO, M
MINEURA, K
ISHII, S
TOMITA, F
JOURNAL OF ANTIBIOTICS, 1980, 33 (09): : 946 - 950
[16] Tumor cell-targeted STING-agonist antibody-drug conjugates achieve potent anti-tumor activity by delivering STING agonist specifically to tumor cells andFcγRI-expressing subset of myeloid cells
Cetinbas, Naniye Malli
Catcott, Kalli C.
Monnell, Travis
Soomer-James, Jahna
Bentley, Keith
Clardy, Susan
Du, Bingfan
Kelleher, Eoin
Protopopova, Marina
Stevenson, Cheri
Thomas, Joshua D.
Uttard, Alex
Toader, Dorin
Duvall, Jeremy
Bukhalid, Raghida
Damelin, Marc
Lowinger, Timothy B.
CANCER RESEARCH, 2022, 82 (12)
[17] PDL192, a novel, humanized antibody to TWEAK receptor, shows potent anti-tumor activity in preclinical models
Culp, P.
Choi, D.
Yin, J.
Tan, S.
Chao, D.
Su, M.
Sho, M.
Steinte, R.
Hsi, E.
Ramakrishnan, V.
EJC SUPPLEMENTS, 2008, 6 (12): : 161 - 161
[18] True small molecule STING agonist generates systemic and potent anti-tumor immunity required for effective cancer immunotherapy
Kulkarni, Meghana M.
Dwight, Timothy
Marino, Kristen
Allen, Bryce K.
Taimi, Mohammed
Bastos, Cecilia
Lai, Sujen
Koh, Cheryl
Samant, Ramya
Tesar, Bethany
Huang, Huang
Chamberlain, Brian
Rice, James M.
Tan, Dazhi
Lin, Zhixiong
Shechter, Sharon
Li, Stella
Sparks, Sam
Soutter, Holly
Swann, Steven
Sherman, Woody
Winter, Christopher
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
[19] Combination of STING agonist with anti-vascular RGD-(KLAKLAK)2 peptide as a novel anti-tumor therapy
Czapla, Justyna
Drzyzga, Alina
Ciepla, Joanna
Matuszczak, Sybilla
Jarosz-Biej, Magdalena
Pilny, Ewelina
Cichon, Tomasz
Smolarczyk, Ryszard
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (08)
[20] STING VAX - A novel tumor vaccine with cyclic dinucleotides - can induce potent anti-tumor responses in vivo.
Dubensky, Thomas W.
Leong, Meredith L.
Kanne, David B.
Lemmens, Edward E.
Metchette, Ken
Liu, Weiqun
Fasso, Marcella
Fu, Juan
Woodward, Joshua J.
Pardoll, Drew
Portnoy, Daniel A.
Kim, Young J.
CANCER RESEARCH, 2013, 73 (08)

← 1 2 3 4 5 →